Bupivacaine With Dexmedetomidine Versus Bupivacaine Alone for Transversus Abdominis Plane Block in Caesarean Section
NCT ID: NCT06292273
Last Updated: 2024-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-10-10
2024-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bupivacaine With or Without Dexmedetomidine for Postoperative Pain Relief in Abdominal Surgery
NCT07285083
Dexmedetomidine Versus Clonidine for Transversus Abdominis Plane Block in Patients Undergoing Elective Caesarean Section
NCT03770013
Pharmacokinetics of BPV Following Bilateral US-guided TAP Block for C-section
NCT03006042
Caudal Block With Bupivacaine and Dexmedetomidine Versus TAP Block With Bupivacaine Alone for Postoperative Analgesia in Pediatric Undergoing Infraumbical Surgeries
NCT06183073
Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.
NCT06324942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Bupivacain Plus dexamethasone
receiving plain bupivacaine 0.1%, 35 ml with dexmedetomidine 0.5
Transversus Abdominis Plane Block with bupivacain Plus dexamethasone
Bupivacain 0.1%, 35 ml with dexmedetomidine 0.5 µG/kg on each side
Group bupivacain
plain bupivacaine 0.25%, 25 ml bilaterally
Transversus Abdominis Plane Block with bupivacain
plain bupivacaine 0.25%, 25 ml bilaterally
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transversus Abdominis Plane Block with bupivacain Plus dexamethasone
Bupivacain 0.1%, 35 ml with dexmedetomidine 0.5 µG/kg on each side
Transversus Abdominis Plane Block with bupivacain
plain bupivacaine 0.25%, 25 ml bilaterally
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASAll
Exclusion Criteria
* BMI\>35
* heart Diseases
* diabets
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menoufia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rabab Mohammad habeeb
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
rabab M habeeb
Role: PRINCIPAL_INVESTIGATOR
Menoufia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Menoufia University
Cairo, Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANET19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.